Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vericel Corp VCEL

Healthcare Biotechnology
Vericel Corporation is a fully-integrated, commercial-stage biopharmaceutical company. The Company is a provider of advanced therapies for the sports medicine and severe burn care markets. It markets three products in the United States. MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous-cellularized scaffold product indicated for the repair of symptomatic... see more

Recent & Breaking News (NDAQ:VCEL)

Five Star Equities Issues New Research Reports on AMRN, ARIA, ASTM and ZIOP

Accesswire October 22, 2013

Aastrom Biosciences One-for-Twenty Reverse Stock Split Now Effective

Globe Newswire October 16, 2013

Aastrom Biosciences Announces One-for-Twenty Reverse Stock Split

Globe Newswire October 10, 2013

Aastrom Biosciences to Present at the 2013 Stem Cell Meeting on the Mesa Conference

Globe Newswire October 10, 2013

Aastrom Biosciences to Present at the Aegis Capital 2013 Healthcare Conference

Globe Newswire September 19, 2013

Aastrom Clinical Trial Application for Phase 2b ixCELL-DCM Study of ixmyelocel-T Approved in Canada

Globe Newswire September 16, 2013

Heidi Hagen Joins Aastrom Board of Directors

Globe Newswire August 26, 2013

Aastrom Biosciences, Inc. Announces Closing of Public Offering of Common Stock and Warrants

Globe Newswire August 16, 2013

Wall Street Fundamentals Releases New In-Depth Stock Reports on ASTM, INO, MACK and VICL

Accesswire August 16, 2013

In the Know, Smart Investing in VALE, PFE, ASTM and PBR

Marketwired August 14, 2013

Aastrom Biosciences, Inc. Announces Pricing of Public Offering of Common Stock and Warrants

Globe Newswire August 13, 2013

Aastrom Biosciences Announces Amendment of Series B Preferred Stock Certificate of Designations, Preferences and Rights

Globe Newswire August 12, 2013

Aastrom Biosciences to Present at the JMP Securities Healthcare Conference

Globe Newswire July 3, 2013

Aastrom Biosciences Reports First Quarter 2013 Financial Results

Globe Newswire May 8, 2013

Aastrom to Host First Quarter 2013 Investor Call on May 8, 2013

Globe Newswire May 3, 2013

Aastrom to Hold Annual Meeting of Shareholders on May 2, 2013

Globe Newswire April 25, 2013

Aastrom Biosciences Announces First Patients Treated in ixCELL-DCM Clinical Study of ixmyelocel-T

Globe Newswire April 19, 2013

Aastrom Biosciences to Present at Multiple Conferences in April

Globe Newswire April 9, 2013

Aastrom Biosciences Announces First Patients Enrolled in ixCELL-DCM Phase 2b Clinical Trial of Ixmyelocel-T

Globe Newswire April 4, 2013

Euro Debt Worries Drag Stocks Lower. Mattress Firm Holding Corp. Helped Push Mattress Companies Higher

PR Newswire March 28, 2013